Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

The prognostic value of clinical and pathologic factors in esophageal adenocarcinoma: a mayo cohort of 796 patients with extended follow-up after surgical resection.

Yoon HH, Khan M, Shi Q, Cassivi SD, Wu TT, Quevedo JF, Burch PA, Sinicrope FA, Diasio RB.

Mayo Clin Proc. 2010 Dec;85(12):1080-9. doi: 10.4065/mcp.2010.0421.

2.

Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas: analysis in more than 900 patients.

Rivadeneira DE, Simmons RM, Christos PJ, Hanna K, Daly JM, Osborne MP.

J Am Coll Surg. 2000 Jul;191(1):1-6; discussion 6-8.

PMID:
10898177
3.

Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.

Jin J, Liao Z, Zhang Z, Ajani J, Swisher S, Chang JY, Jeter M, Guerrero T, Stevens CW, Vaporciyan A, Putnam J Jr, Walsh G, Smythe R, Roth J, Yao J, Allen P, Cox JD, Komaki R.

Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):427-36.

PMID:
15380576
4.

Pathologic prognostic factors in Barrett's associated adenocarcinoma: a follow-up study of 96 patients.

Torres C, Turner JR, Wang HH, Richards W, Sugarbaker D, Shahsafaei A, Odze RD.

Cancer. 1999 Feb 1;85(3):520-8.

PMID:
10091725
5.

Factors affecting long-term survival after en-bloc resection of lung cancer invading the chest wall.

Chapelier A, Fadel E, Macchiarini P, Lenot B, Le Roy Ladurie F, Cerrina J, Dartevelle P.

Eur J Cardiothorac Surg. 2000 Nov;18(5):513-8.

PMID:
11053809
6.

Tumor length as a prognostic factor in esophageal malignancy: univariate and multivariate survival analyses.

Griffiths EA, Brummell Z, Gorthi G, Pritchard SA, Welch IM.

J Surg Oncol. 2006 Mar 15;93(4):258-67.

PMID:
16496364
7.

Pretreatment surgical lymph node staging predicts results of trimodality therapy in esophageal cancer.

Jiao X, Krasna MJ, Sonett J, Gamliel Z, Suntharalingam M, Doyle A, Greenwald B.

Eur J Cardiothorac Surg. 2001 Jun;19(6):880-6.

PMID:
11404146
8.

Pretreatment T3-4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy.

Chao YK, Chan SC, Liu YH, Chen HW, Wan YL, Chang HK, Fan KH, Liu HP.

Ann Surg. 2009 Mar;249(3):392-6. doi: 10.1097/SLA.0b013e3181949e9f.

PMID:
19247024
10.

Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators.

Sohn TA, Yeo CJ, Cameron JL, Koniaris L, Kaushal S, Abrams RA, Sauter PK, Coleman J, Hruban RH, Lillemoe KD.

J Gastrointest Surg. 2000 Nov-Dec;4(6):567-79.

PMID:
11307091
11.

Tobacco use is associated with increased recurrence and death from gastric cancer.

Smyth EC, Capanu M, Janjigian YY, Kelsen DK, Coit D, Strong VE, Shah MA.

Ann Surg Oncol. 2012 Jul;19(7):2088-94. doi: 10.1245/s10434-012-2230-9. Epub 2012 Mar 7.

PMID:
22395977
12.

[Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].

Tu H, Huang H, Huang QD, Li Z, Feng YL, Liu JH.

Zhonghua Fu Chan Ke Za Zhi. 2012 Dec;47(12):928-33. Chinese.

PMID:
23324194
13.

Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer.

Greenstein AJ, Litle VR, Swanson SJ, Divino CM, Packer S, Wisnivesky JP.

Cancer. 2008 Mar 15;112(6):1239-46. doi: 10.1002/cncr.23309.

14.

[Prognostic analysis of clinicopathological factors in patients after radical resection of esophageal carcinoma].

Zhu SC, Song CL, Shen WB, Su JW, Li J, Liu ZK.

Zhonghua Zhong Liu Za Zhi. 2012 Apr;34(4):281-6. doi: 10.3760/cma.j.issn.0253-3766.2012.04.010. Chinese.

PMID:
22781041
15.

Do tumor grade and location affect survival in esophageal squamous cell carcinoma? Survival analysis of 302 cases of pT3N0M0 esophageal squamous cell carcinoma.

Situ D, Wei W, Lin P, Long H, Zhang L, Fu J, Rong T, Ma G.

Ann Surg Oncol. 2013 Feb;20(2):580-5. doi: 10.1245/s10434-012-2656-0. Epub 2012 Sep 27.

PMID:
23015029
16.

Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment.

Altorki NK, Lee PC, Liss Y, Meherally D, Korst RJ, Christos P, Mazumdar M, Port JL.

Ann Surg. 2008 Mar;247(3):434-9. doi: 10.1097/SLA.0b013e318163a2ff.

PMID:
18376186
17.

Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.

Lee PC, Port JL, Paul S, Stiles BM, Altorki NK.

Ann Thorac Surg. 2009 Jul;88(1):186-92; discussion 192-3. doi: 10.1016/j.athoracsur.2009.03.079.

PMID:
19559222
18.
19.

[Patients surviving 5 years after curative oesophagectomy for oesophageal cancer].

Mariette C, Fabre S, Balon JM, Piessen G, Lamblin A, Triboulet JP.

Ann Chir. 2003 Oct;128(8):536-42. French.

PMID:
14559305
20.

[Long-term survival after eso-gastrectomy for esophagogastric junction adenocarcinoma--prospective study].

Bîrlă R, Iosif C, Mocanu A, Gîndea C, Hoară P, Panaitescu E, Constantinoiu S.

Chirurgia (Bucur). 2008 Nov-Dec;103(6):635-42. Romanian.

PMID:
19274907

Supplemental Content

Support Center